Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × INDUSTRY × Glioma × Clear all

Status

Completed 105 Terminated 34 Recruiting 30 Active not recruiting 20 Unknown 13 Not yet recruiting 13 Withdrawn 5 No longer available 3 Approved for marketing 3 Suspended 2 Enrolling by invitation 2 Available 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Sarcoma 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Recurrence 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Primary Myelofibrosis 2 Non-Muscle Invasive Bladder Neoplasms 2 Neuroblastoma 2 Neoplasm Metastasis 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Brain Neoplasms 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06743100 2025-04-02

18F-Floretyrosine Expanded Access Program

Telix Pharmaceuticals (Innovations) Pty Limited

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡